Latest News

We wouldn't blame Lear Corporation ( NYSE:LEA ) shareholders if they were a little worried about the fact that Jason...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

MillerKnoll, Inc. ( NASDAQ:MLKN ) shareholders are no doubt pleased to see that the share price has bounced 30% in the...

EDAP TMS S.A. ( NASDAQ:EDAP ) shareholders would be excited to see that the share price has had a great month, posting...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

XPEL (XPEL) has announced an aggressive two-year capital spending plan of up to $150 million, and insiders are backing it with their own money, as six executives have recently bought shares. See our latest analysis for XPEL. The backdrop to this spending push is a stock that has caught a strong tailwind, with a 30 day share price return of 20.0 percent and a 90 day share price return of 54.0 percent. However, a three year total shareholder return of negative 13.7 percent shows that longer...

Earlier this week, Jabil Inc. reported first-quarter fiscal 2026 results, with sales rising to US$8,305 million and net income to US$146 million, alongside higher earnings per share and an increased full-year 2026 revenue outlook of US$32.40 billion. The company highlighted especially strong momentum in its Intelligent Infrastructure and AI-related businesses, and pointed to the planned Hanley Energy acquisition as a way to deepen its role in data center power and energy systems. We’ll now...

In December 2025, QIAGEN announced it would return about US$500,000,000 to shareholders through a synthetic share repurchase that combines a direct capital repayment with a reverse stock split, aiming to cut its share count by roughly 5% by early January 2026. This move means QIAGEN will have already exceeded its pledge to return at least US$1.00 billion to shareholders by the end of 2028, and it is now considering further ways to increase shareholder returns from 2026 onward. We’ll now...

Avnet (AVT) just landed a meaningful expansion of its distribution deal with Navitas Semiconductor, strengthening their partnership around next generation GaN and SiC power devices for fast growing AI and clean energy markets. See our latest analysis for Avnet. The expanded Navitas deal lands at a time when sentiment around Avnet has been a bit mixed, with a roughly 10 percent 1 month share price return but a slightly negative year to date share price performance. At the same time, the 3 year...

If you are wondering whether Southern is still a sensible buy at around $85 a share, or if the best gains are already behind it, this is the right place to unpack what the current price really implies. Despite some recent choppiness, with the stock up 1.0% over the last week but down 4.2% over the past 30 days, Southern still sits modestly ahead year to date at 3.9%, with a 6.4% 1-year return and 32.6% and 72.3% gains over 3 and 5 years respectively. Recent headlines have focused on...

Recent performance sets the stage Olin (OLN) has quietly slipped over the past week but is still up over the past month, a choppy setup that makes its longer slide this year more interesting for value minded investors. See our latest analysis for Olin. That recent pullback comes on top of a much steeper year to date share price decline, while multi year total shareholder returns remain deeply negative. This pattern signals fading momentum and persistent market skepticism about Olin’s earnings...

In recent days, Rogers Communications has launched Amazon Luna cloud gaming on Rogers Xfinity, expanded Rogers Satellite services for remote consumer and IoT connectivity, and extended its 5G mobile network to 34 additional eastern Ontario communities through the EORN Cell Gap Project. Together, these moves show Rogers using its network scale to bundle entertainment, satellite-to-mobile links, and rural 5G coverage into a broader connectivity ecosystem for Canadian households, businesses,...

CARsgen Therapeutics Holdings recently reported that its BCMA-targeted CAR-T therapy zevorcabtagene autoleucel was added to China’s new Commercial Health Insurance Innovative Drug Catalogue, while early clinical data for its allogeneic BCMA CAR-T candidate CT0596 were presented at the 67th ASH Congress with favorable tolerability and efficacy signals. Together, these updates underline CARsgen’s progress across both approved and next-generation BCMA therapies, signaling broader potential...

Earlier this month, Ally Financial Inc. announced a new share repurchase program of up to US$2.00 billion with no expiration date, alongside the retirement of long-serving director Marjorie Magner from its board. At the same time, multiple Wall Street firms upgraded their views on Ally, highlighting the buyback and an improving auto finance outlook as key supports for the company’s capital return and earnings profile. We’ll now explore how Ally’s freshly announced US$2.00 billion buyback may...

Aktia Pankki Oyj (HLSE:AKTIA) has quietly pushed higher, with the share price up about 12% over the past month and more than 40% over the past year, catching many Finland bank investors’ attention. See our latest analysis for Aktia Pankki Oyj. That steady 11.40% 1 month share price return and 41.38% 1 year total shareholder return suggest momentum is still building, as investors warm to Aktia’s earnings resilience, modest growth and income profile at the current €11.92 share price. If Aktia’s...

XP (NasdaqGS:XP) has come back into focus after CEO Thiago Maffra laid out new 2026 priorities, ranging from alternative distribution channels to broader premium services, paired with fresh Wall Street commentary on its strategy and challenges. See our latest analysis for XP. Despite the CEO’s fresh 2026 roadmap and mixed brokerage commentary, XP’s recent stretch has been choppy, with a 30 day share price return of minus 11.06 percent and a 90 day share price return of minus 18.98 percent. At...

Helmerich & Payne (HP) is back on investors radar after a flurry of upgrades, as Wall Street warms to its deleveraging plan, tighter capex, and exposure to Saudi drilling demand despite recent earnings noise. See our latest analysis for Helmerich & Payne. Those upgrades land after a choppy year, with a 36.03% 3 month share price return off the lows. Even so, year to date share price performance remains negative, while the 1 year total shareholder return of minus 3.98% shows sentiment is only...

Kyowa Kirin (TSE:4151) just gave investors a fresh data point to chew on, with new KOMZIFTI combination trial results in acute myeloid leukemia highlighting encouraging activity alongside a clean looking safety profile. See our latest analysis for Kyowa Kirin. Those KOMZIFTI data land as Kyowa Kirin’s 90 day share price return of 7.9% and roughly 9% year to date share price gain suggest sentiment is quietly improving, even though the three year total shareholder return is still in negative...

In December 2025, ManpowerGroup entered a new US$600 million five-year revolving credit facility and issued €500 million of 3.750% senior unsecured notes due 2030, using the proceeds to redeem its existing €500 million 1.750% notes maturing in 2026 without incurring early termination penalties. This refinancing refreshes ManpowerGroup’s debt structure, potentially easing covenant pressure through higher allowances for restructuring charges and extending its debt maturity profile. Next,...

Niron Magnetics and Moog (MOG.A) just unveiled a partnership to test Iron Nitride based actuators for guided munitions, tying Moog directly into the U.S. defense push for resilient, domestically sourced tech. See our latest analysis for Moog. The news comes on top of a strong run, with Moog’s share price up 25.4 percent over the past month and 26.1 percent over the last quarter, while its five year total shareholder return above 200 percent suggests momentum has been building for some...

Earlier this month, Iron Mountain filed a US$386.31 million shelf registration for 4,600,000 common shares tied to an ESOP-related offering. Coming alongside upbeat analyst coverage and improved quarterly revenue and net profit, the ESOP-focused filing highlights management’s confidence in employee ownership and long-term alignment. Next, we’ll examine how the strong quarterly revenue and profit performance shapes Iron Mountain’s broader investment narrative and risk profile. AI is about to...

China’s video game industry revenue reached a record high this year, rising 7.7% to ¥350.80 billion, supported by domestic hits from Tencent and NetEase, government policy, overseas demand, and AI-related innovation. NetEase’s push into international markets, especially the US, Japan, and Korea via mobile titles, has become a key driver of its growing global footprint within this expanding industry. We’ll now look at how China’s record gaming revenue and NetEase’s overseas growth influence...

Sovereign Metals (ASX:SVM) just locked in a collaboration agreement with the International Finance Corporation for its Kasiya rutile graphite project in Malawi, sharpening both its financing path and sustainability credentials. See our latest analysis for Sovereign Metals. The IFC partnership lands after a volatile stretch for Sovereign Metals, with a 7 day share price return of 28.12 percent and a year to date share price return of negative 17.45 percent. The 5 year total shareholder return...

Summit Therapeutics (SMMT) is back on investors’ radar after fresh bullish commentary from Cantor Fitzgerald and a rating upgrade from Barclays, both zeroing in on ivonescimab and the upcoming HARMONi-3 phase 3 trial. See our latest analysis for Summit Therapeutics. The bullish focus on ivonescimab and HARMONi-3 has coincided with a 7.61% one-month share price return to $17.82, while the three-year total shareholder return of 385.56% underscores how momentum has transformed longer-term...